Valsts: Jaunzēlande
Valoda: angļu
Klimata pārmaiņas: Medsafe (Medicines Safety Authority)
Heparin sodium 1000 IU/mL;
Pfizer New Zealand Limited
Heparin sodium 1000 IU/mL
5000 IU/5mL
Solution for injection
Active: Heparin sodium 1000 IU/mL Excipient: Hydrochloric acid Sodium hydroxide Water for injection
Ampoule, plastic, 5 mL lLDPE ampoules, 10s, 50 mL
Prescription
Prescription
Pharmacia Hepar LLC
Package - Contents - Shelf Life: Ampoule, plastic, 5 mL lLDPE ampoules - 10 dose units - 24 months from date of manufacture stored at or below 25°C - Ampoule, plastic, 5 mL lLDPE ampoules - 50 dose units - 24 months from date of manufacture stored at or below 25°C
2009-04-21
HEPARIN INJECTION 1 HEPARIN INJECTION _ _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Heparin Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you using Heparin Injection against the benefits this medicine is expected to have for you. This medicine is likely to be used while you are at the clinic or in hospital. If possible, please read this leaflet carefully before this medicine is given to you. In some cases this leaflet may be given to you after the medicine has been used. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT HEPARIN INJECTION IS USED FOR Heparin Injection belongs to a group of medicines known as anticoagulants. Anticoagulants work by decreasing the clotting ability of your blood and help stop clots forming in the blood vessels. Anticoagulants are sometimes called "blood thinners", although they do not actually thin the blood. Heparin will not dissolve blood clots that have already formed, but it may prevent any clots that have already formed from becoming larger and causing serious problems. Heparin Injection is used for prevention and treatment of diseases caused by blood clots such as in certain blood vessel, heart and lung conditions. It is also used to prevent blood clots from forming during surgery, dialysis or blood transfusions. Heparin Injection may be used for the treatment of other conditions that are not mentioned above. Your doctor will be able to tell y Izlasiet visu dokumentu
Version: pfdhepai11220 Supersedes: pfdhepai10219 Page 1 of 14 NEW ZEALAND DATA SHEET 1. PRODUCT NAME _ _ Heparin Sodium (Pfizer) 5000 IU/5mL, 25000 IU/5mL Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One ampoule contains Heparin sodium 1000 IU/mL or 5000 IU/mL, in 5mL ampoules Heparin sodium is a white or almost white powder, moderately hygroscopic, freely soluble in water. Heparin sodium is a preparation containing the sodium salt of a sulphated glucosaminoglycan present in mammalian tissues. It is prepared from the lungs or from the intestinal mucosae of pigs. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection Heparin Injection is a clear, colourless to straw coloured, sterile, preservative-free solution containing Heparin Sodium BP (porcine mucous) in Water for Injections BP. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS • prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. • as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. • as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes. 4.2 DOSE AND METHOD OF ADMINISTRATION DOSE Heparin Injection contains no antimicrobial agent and is therefore intended for single use only. Heparin may be given by intermittent intravenous injection, intravenous infusion or deep subcutaneous injection. It should not be given intramuscularly due to the risk of haematoma Version: pfdhepai11220 Supersedes: pfdhepai10219 Page 2 of 14 formation at the injection site. There is a wide variation between individuals in the dose required to control thromboembolism and heparin dose is usually determined empirically by adjustment according to the results of laboratory tests. THE DOSAGE OF HEPARIN SODIUM SHOULD BE ADJUSTED ACCORDING Izlasiet visu dokumentu